Study Suggests Link Between Type 2 Diabetes and Low Melatonin

Published Online: Friday, May 17, 2013
Follow Pharmacy_Times:
Women with low levels of melatonin may be at a higher risk for developing type 2 diabetes, according to a recent study published in the April 3, 2013, issue of the Journal of the American Medical Association.

The study included 370 women from the U.S. Nurses’ Health Study who developed type 2 diabetes from 2000 to 2012 and 370 non-diabetic controls. Melatonin levels were measured through urine and blood samples before the development of diabetes. When analyzing the relationship between melatonin and diabetes development, the researchers evaluated other risk factors such as demographics, eating habits, and sleep patterns.

Women with the lowest levels of melatonin were 2.17 times more likely to develop type 2 diabetes than women with the highest melatonin levels.

“While there is a correlation between melatonin and insulin resistance, we cannot tell from this study if low melatonin is the cause,” said Dr. Joel Zonszein, director of the clinical diabetes center at Montefiore Medical Center in New York City, in a press release. “We are far away from melatonin as a treatment.”

The authors conclude that more research is needed to determine if low melatonin levels are a risk factor for type 2 diabetes in the general population.


Related Articles
Excess medical costs for diabetes and lost productivity amounted to more than $322 billion in 2012, a 48% increase from the $218 billion estimate for 2007.
Patients with type 2 diabetes mellitus may see a reduction in blood sugar levels and body weight with empagliflozin treatment, according to data from Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals Inc.
Implementing eye screening via telemedicine among patients with diabetes uncovered that 1 in 5 have diabetic retinopathy.
Latest Issues
$auto_registration$